Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 140

1.

BCR targets cyclin D2 via Btk and the p85alpha subunit of PI3-K to induce cell cycle progression in primary mouse B cells.

Glassford J, Soeiro I, Skarell SM, Banerji L, Holman M, Klaus GG, Kadowaki T, Koyasu S, Lam EW.

Oncogene. 2003 Apr 17;22(15):2248-59.

PMID:
12700661
2.

Recirculating and germinal center B cells differentiate into cells responsive to polysaccharide antigens.

Vinuesa CG, Sze DM, Cook MC, Toellner KM, Klaus GG, Ball J, MacLennan IC.

Eur J Immunol. 2003 Feb;33(2):297-305.

3.

CD40 regulates the processing of NF-kappaB2 p100 to p52.

Coope HJ, Atkinson PG, Huhse B, Belich M, Janzen J, Holman MJ, Klaus GG, Johnston LH, Ley SC.

EMBO J. 2002 Oct 15;21(20):5375-85.

4.

BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.

Banerji L, Glassford J, Lea NC, Thomas NS, Klaus GG, Lam EW.

Oncogene. 2001 Nov 1;20(50):7352-67.

5.

Vav is required for cyclin D2 induction and proliferation of mouse B lymphocytes activated via the antigen Receptor.

Glassford J, Holman M, Banerji L, Clayton E, Klaus GG, Turner M, Lam EW.

J Biol Chem. 2001 Nov 2;276(44):41040-8. Epub 2001 Sep 6.

6.

A method for investigating the role of homotypic adhesion in lymphocyte activation.

Cliff JM, Klaus GG.

J Immunol Methods. 2000 Dec 1;246(1-2):51-9.

PMID:
11121546
7.

Cyclin D2 is essential for BCR-mediated proliferation and CD5 B cell development.

Solvason N, Wu WW, Parry D, Mahony D, Lam EW, Glassford J, Klaus GG, Sicinski P, Weinberg R, Liu YJ, Howard M, Lees E.

Int Immunol. 2000 May;12(5):631-8.

PMID:
10784609
8.

Germinal centers without T cells.

de Vinuesa CG, Cook MC, Ball J, Drew M, Sunners Y, Cascalho M, Wabl M, Klaus GG, MacLennan IC.

J Exp Med. 2000 Feb 7;191(3):485-94.

9.

Cyclin D3 compensates for loss of cyclin D2 in mouse B-lymphocytes activated via the antigen receptor and CD40.

Lam EW, Glassford J, Banerji L, Thomas NS, Sicinski P, Klaus GG.

J Biol Chem. 2000 Feb 4;275(5):3479-84.

10.

Dendritic cells associated with plasmablast survival.

García De Vinuesa C, Gulbranson-Judge A, Khan M, O'Leary P, Cascalho M, Wabl M, Klaus GG, Owen MJ, MacLennan IC.

Eur J Immunol. 1999 Nov;29(11):3712-21.

11.

Modulation of E2F activity in primary mouse B cells following stimulation via surface IgM and CD40 receptors.

Lam EW, Glassford J, van der Sman J, Banerji L, Pizzey AR, Shaun N, Thomas B, Klaus GG.

Eur J Immunol. 1999 Oct;29(10):3380-9.

12.

Anti-CD40 antibody enhances responses to polysaccharide without mimicking T cell help.

García de Vinuesa C, MacLennan IC, Holman M, Klaus GG.

Eur J Immunol. 1999 Oct;29(10):3216-24.

13.

Interaction of B cells with activated T cells reduces the threshold for CD40-mediated B cell activation.

Klaus GG, Holman M, Johnson-Léger C, Christenson JR, Kehry MR.

Int Immunol. 1999 Jan;11(1):71-9.

PMID:
10050675
14.

MAPkinase: a second site of G-protein regulation of B-cell activation via the antigen receptors.

Deehan MR, Klaus GG, Holman MJ, Harnett W, Harnett MM.

Immunology. 1998 Oct;95(2):169-77.

15.

Evidence for a critical role for IL-2 in CD40-mediated activation of naive B cells by primary CD4 T cells.

Johnson-Léger C, Christenson JR, Holman M, Klaus GG.

J Immunol. 1998 Nov 1;161(9):4618-26.

16.

Antigen-specific T lymphocytes regulate lipopolysaccharide-induced apoptosis of dendritic cells in vivo.

De Smedt T, Pajak B, Klaus GG, Noelle RJ, Urbain J, Leo O, Moser M.

J Immunol. 1998 Nov 1;161(9):4476-9.

17.

Monoclonal antibody therapy of B cell lymphoma: signaling activity on tumor cells appears more important than recruitment of effectors.

Tutt AL, French RR, Illidge TM, Honeychurch J, McBride HM, Penfold CA, Fearon DT, Parkhouse RM, Klaus GG, Glennie MJ.

J Immunol. 1998 Sep 15;161(6):3176-85.

18.

CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells.

Johnson-Léger C, Christensen J, Klaus GG.

Int Immunol. 1998 Aug;10(8):1083-91.

PMID:
9723694
19.

Modulation of E2F activity via signaling through surface IgM and CD40 receptors in WEHI-231 B lymphoma cells.

Lam EW, Choi MS, van der Sman J, Burbidge SA, Klaus GG.

J Biol Chem. 1998 Apr 17;273(16):10051-7.

20.

A re-evaluation of the effects of X-linked immunodeficiency (xid) mutation on B cell differentiation and function in the mouse.

Klaus GG, Holman M, Johnson-Léger C, Elgueta-Karstegl C, Atkins C.

Eur J Immunol. 1997 Nov;27(11):2749-56.

PMID:
9394795
21.

The effects of IFN-gamma on CD40-mediated activation of B cells from X-linked immunodeficient or normal mice.

Johnson-Léger C, Hasbold J, Holman M, Klaus GG.

J Immunol. 1997 Aug 1;159(3):1150-9.

PMID:
9233608
22.

CD40: a pivotal receptor in the determination of life/death decisions in B lymphocytes.

Klaus GG, Choi MS, Lam EW, Johnson-Léger C, Cliff J.

Int Rev Immunol. 1997;15(1-2):5-31. Review.

PMID:
9178070
23.

Properties of mouse CD40: differential expression of CD40 epitopes on dendritic cells and epithelial cells.

Van Den Berg TK, Hasbold J, Renardel De Lavalette C, Döpp EA, Dijkstra CD, Klaus GG.

Immunology. 1996 Jun;88(2):294-300.

24.

Expression of bcl-x during mouse B cell differentiation and following activation by various stimuli.

Choi MS, Holmann M, Atkins CJ, Klaus GG.

Eur J Immunol. 1996 Mar;26(3):676-82.

PMID:
8605937
25.

The role of bcl-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells.

Choi MS, Boise LH, Gottschalk AR, Quintans J, Thompson CB, Klaus GG.

Eur J Immunol. 1995 May;25(5):1352-7.

PMID:
7539757
26.
27.

Properties of mouse CD40: the role of homotypic adhesion in the activation of B cells via CD40.

Klaus GG, Holman M, Hasbold J.

Eur J Immunol. 1994 Nov;24(11):2714-9.

PMID:
7525301
28.

Properties of mouse CD40: cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies.

Hasbold J, Johnson-Léger C, Atkins CJ, Clark EA, Klaus GG.

Eur J Immunol. 1994 Aug;24(8):1835-42.

PMID:
7519998
29.

Induction of NF-AT in normal B lymphocytes by anti-immunoglobulin or CD40 ligand in conjunction with IL-4.

Choi MS, Brines RD, Holman MJ, Klaus GG.

Immunity. 1994 Jun;1(3):179-87.

PMID:
7889406
30.

Plastic-immobilized anti-mu or anti-delta antibodies induce apoptosis in mature murine B lymphocytes.

Parry SL, Holman MJ, Hasbold J, Klaus GG.

Eur J Immunol. 1994 Apr;24(4):974-9.

PMID:
7512037
31.
32.

B cells from CBA/N mice do not proliferate following ligation of CD40.

Hasbold J, Klaus GG.

Eur J Immunol. 1994 Jan;24(1):152-7.

PMID:
7517360
33.
36.
38.
39.
40.

Cross-talk between surface immunoglobulin and interleukin-4 receptors on murine B-lymphocytes.

Klaus GG, Harnett MM.

Biochem Soc Trans. 1991 Apr;19(2):272-5. Review. No abstract available.

PMID:
1653730
42.

Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas.

Hasbold J, Klaus GG.

Eur J Immunol. 1990 Aug;20(8):1685-90.

PMID:
2209683
43.

Role of G-proteins in receptor signalling in T and B cells.

Klaus GG.

Semin Immunol. 1990 Mar;2(2):151-7. Review.

PMID:
2151799
44.

Analysis of signaling via surface immunoglobulin receptors on B cells from CBA/N mice.

Rigley KP, Harnett MM, Phillips RJ, Klaus GG.

Eur J Immunol. 1989 Nov;19(11):2081-6.

PMID:
2557221
45.
47.

Regulation of the polyphosphoinositide-specific phosphodiesterase in B lymphocytes.

Klaus GG, Harnett MM, Rigley KP.

Cold Spring Harb Symp Quant Biol. 1989;54 Pt 2:723-31. No abstract available.

PMID:
2561804
48.

G-protein regulation of polyphosphoinositide breakdown in B cells.

Klaus GG, Harnett MM, Rigley KP.

Adv Exp Med Biol. 1989;254:95-100. No abstract available.

PMID:
2554696
50.

G protein regulation of receptor signalling.

Harnett MM, Klaus GG.

Immunol Today. 1988 Oct;9(10):315-20. Review. No abstract available.

PMID:
3151244

Supplemental Content

Loading ...
Support Center